Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease

por Bailey, Christopher, Wei, Yuanyi, Yan, Jinsong, Huang, Dan, Zhang, Peng, Qi, Chong, Lazarski, Christopher, Su, JuanJuan, Tang, Fei, Wong, Chun-shu, Zheng, Pan, Liu, Yan, Liu, Yang, Wang, Yin
Publicado 2023